CME Group Inc. Class A (CME)
NASDAQ: CMEFinanceInvestment Bankers/Brokers/ServiceUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
CME stock chart
Technical analysisKey statistics
All statistics- Market cap
- $110.09B
- P/E (TTM)
- 25.21
- Forward P/E
- 23.21
- EPS (TTM)
- $12.20
- Dividend yield
- 1.67% ($5.15)
- Ex-dividend date
- Dec 11, 2026
- 52-week range
- 218.31 – 329.16
- Day range
- 306.88 – 313.10
- Volume / Avg
- 2.68M / 1.96M
- Beta
- —
- Shares outstanding
- 357.93M
52-week range
CME stock today
Shares of CME Group (CME) finished higher on Nov 20 at $307.56, a gain of 0.41% or $1.25 per share, versus the S&P 500's 3.70% decline. Shares are 6.6% below their 52-week high of $329.16, set on Mar 3, 2026 and 40.9% above the 52-week low of $218.31, near the top of the past year's range. CME is up 12.6% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 12.6%.
At 25.2x trailing earnings, CME Group trades in line with the peer-group median of 25.3x. Its forward P/E of 23.2x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. CME Group pays an annual dividend of $5.15 per share, a 1.67% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About CME Group
Company profileCME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, and foreign exchange; and agricultural, energy, and metals commodities, as well as fixed income and foreign currency trading services. The company provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges.
- Sector
- Finance
- Industry
- Investment Bankers/Brokers/Service
- CEO
- Mr. Terrence A. Duffy
- Headquarters
- Chicago, IL
- Employees
- 3,875
- IPO year
- 2002
- Website
- cmegroup.com
Financial highlights
Full financialsIn fiscal 2025, CME Group generated $6.52 billion in revenue, up 6.4% from fiscal 2024, its 4th consecutive year of revenue growth. Net income was $4.07 billion (+15.5% year over year), for a net margin of 62.5% versus a median of 56.2% in the prior 5 years. Operating margin was 64.9%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $6.52B | $6.13B | $5.58B | $5.02B | $4.69B |
| Growth | +6.37% | +9.88% | +11.15% | +7.03% | -3.97% |
| Net income | $4.07B | $3.53B | $3.23B | $2.69B | $2.64B |
| EPS (diluted) | $11.16 | $9.67 | $8.86 | $7.40 | $7.29 |
Analyst forecast
ForecastConsensus (17 analysts)
buy
Avg. price target
$317.06+3.09%
- Strong buy 5
- Buy 4
- Hold 6
- Sell 1
- Strong sell 1
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Oct 21, 2026
- EPS actual vs est.
- $3.02 vs $2.98
- Surprise
- +1.34%
Dividends
Dividend history- Annual dividend
- $5.15
- Dividend yield
- 1.67%
- Last payment
- $1.30
- Ex-dividend date
- Dec 11, 2026
- Pay date
- Dec 30, 2026
CME news
All CME news- CME vs. Robinhood Markets: Which Financial Stock Is a Better Buy for 2027?NasdaqCME, HOOD, HEI.A
- Why Is CME (CME) Up 0.1% Since Last Earnings Report?Nasdaq
- JGLO, MA, CME, JNJ: ETF Outflow AlertNasdaqJGLO, MA, CME, JNJ
- CME vs. Upstart: Which Financial Stock Is a Better Buy for 2027?NasdaqCME, UPST
- CME vs. Toast: Which Financial Stock Is a Better Buy for 2027?NasdaqCME, TOST
- Will Senators' Pushback Derail Robinhood's Prediction-Market Growth?NasdaqHOOD, CME, IBKR, FLUT
- CME vs. Morningstar: Which Financial Stock Is a Better Buy for 2027?NasdaqCME, MORN
- CME Group: Dividend Growth Investors Shouldn't Ignore This StockSeeking Alpha
CME Group peers
Finance sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| IBKRInteractive Brokers Group Inc. Class A | 71.19 | -5.90% | $121.30B | vs CME |
| ICEIntercontinental Exchange Inc. | 170.00 | -0.52% | $95.01B | vs CME |
| SCHWCharles Schwab Corporation (The) | 90.16 | -2.13% | $155.62B | vs CME |
| NDAQNasdaq Inc. | 102.92 | -0.99% | $57.12B | vs CME |
| HOODRobinhood Markets Inc. Class A | 62.17 | -9.44% | $55.98B | vs CME |
| BLKBlackRock Inc. | 1,101.72 | -3.00% | $170.13B | vs CME |
| CBOECboe Global Markets Inc. | 357.71 | +0.01% | $37.32B | vs CME |
| RJFRaymond James Financial Inc. | 155.82 | -1.93% | $29.93B | vs CME |
Indexes, lists and sector
CME Group stock FAQ
What is CME Group's stock price today?
CME last traded at $307.56 as of Nov 20, 4:00 PM EST, up 0.41% on the day. Prices are delayed at least 15 minutes.
Does CME Group pay a dividend?
Yes. CME Group pays $5.15 per share annually, a 1.67% yield. The most recent dividend of $1.30 had an ex-dividend date of Dec 11, 2026.
What is CME's P/E ratio?
CME trades at a trailing P/E ratio of 25.21 and a forward P/E of 23.21, compared with a median of 25.3 for its closest peers.
Is CME Group in the S&P 500?
Yes. CME Group (CME) is a constituent of the S&P 500 index.
Who is CME Group's CEO?
Mr. Terrence A. Duffy is the chief executive officer of CME Group Inc. Class A, which has about 3,875 employees.
Has CME ever split its stock?
Yes. The most recent CME stock split was a 5-for-1 split on Jul 23, 2012.
What is the CME 52-week high?
The 52-week high for CME is $329.16 and the 52-week low is $218.31. The stock is currently 6.6% below its high.